About: Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

AttributesValues
value
  • Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients
subject
  • Alzheimer's disease
  • Zoonoses
  • COVID-19
  • EC 3.4.24
  • Tumor markers
  • Angiotensin II receptor antagonists
  • Antihypertensive agents
  • Combination drugs
  • Sarbecovirus
  • Chiroptera-borne diseases
  • Infraspecific virus taxa
  • Novartis brands
part of
is hasSource of
is resource representing a document's title of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software